Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry

Background: Patients (pts) with hematologic disease are at increased risk of severe SARS-CoV-2 infection. Recent observations reported poor outcomes of COVID-19 in pts with various cancer types and higher mortality rates compared with the general population. However, currently available data on COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavrilina, Olga A., Zakurdaeva, Kristina, Vorobyev, Vladimir I., Vasileva, Anastasia N., Butaev, Lev S., Sukhareva, Alena, Gavrilova, Lubov, Samoylova, Olga, Grishunina, Maria, Ochirova, Ochsana, Karpova, Alina, Panteleeva, Olga, Kunst, Mikhail A., Shuvaev, Vasily, Rakhmani, Anzhelika, Gaponova, Tatiana V., Galstyan, Gennadiy M., Troitskaya, Vera V., Luchkin, Anton V., Parovichnikova, Elena N., Savchenko, Valery
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
904.Outcomes Research-Non-Malignant Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330244/
http://dx.doi.org/10.1182/blood-2020-138504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330244/
http://dx.doi.org/10.1182/blood-2020-138504

Ejemplares similares